Treatment for cancer and compounds for use therein
CA 2278159 A1 · Owner: Sakalosky, George P. · Inventors: Sakalosky, George P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A treatment for cancer and compounds for use therewith are provided. The compounds treat cancer by correcting a TATA box lesion in DNA that leads to the cancer's uncontrolled cell proliferation. The preferred compounds each contain strontium; iodine; ascorbic acid; and a diamagnetic ion either , bismuth, zinc, or potassium. These components orient the components transport , it to lesion, dissociate the aberrational bonds of the lesion hydrogenate the , dissociated TATA nucleotides at the lesion and reconvert the lesion's , chemical structure to that of normal DNA.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 12, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 12, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 12, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.